A13: B cells as drivers towards clinical systemic lupus erythematosus manifestation
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterised by the production of autoantibodies, particularly against nuclear antigens that form immune complexes and lead to widespread organ damage. These autoantibodies are produced by plasma cells (PCs), which are terminally differentiated B cells specialised in antibody secretion.
Autoantibody producing PCs are oftentimes resistant to conventional immunosuppressive therapies, highlighting the need to identify novel therapeutic targets.
PCs can survive for extended periods within specialised microenvironments called survival niches and provide essential survival signals. While long-lived PCs are known to reside in bone marrow niches, under inflammatory conditions other organs such as the spleen and kidney can support PC survival.
In a first part of the project, we aim to investigate the composition and characteristics of PC survival niches within the spleen of lupus-prone mice.

- Projects
- 1st Generation
- 2nd Generation
- A: Defining Autoimmune Pre-Disease
- A10: Define the impact of shift work on autoimmunity and autoimmune diseases
- A11: T cell memory differentiation in early autoimmune disease
- A12: Genetic and molecular similarity of autoimmune diseases
- A13: B cells as drivers towards clinical systemic lupus erythematosus manifestation
- A14: Exploring novel genetic variants and the pathogenicity of autoantibodies in patients with pemphigus vulgaris and their first-degree relatives
- A15: Investigating the role of C5aR2 in B cell functions and autoimmune diseases
- A16: Co-inhibitory and -stimulatory cell surface receptors and their ligands in the regulation of pemphigoid diseases
- B: Targeting of Autoimmune Pre-Disease
- Associated projects
- Medical doctoral researcher projects
- Concluded projects
- A: Defining Autoimmune Pre-Disease
Doctoral researcher

Participating Researchers


Mentor
